For many women, receiving an endometriosis diagnosis is the end of a long road — sometimes years of being told their pain was normal, dismissed as anxiety, or attributed to something else entirely. When a stage number is finally attached to that diagnosis, it can feel like the first concrete piece of information they have been given. But the staging system for endometriosis is one of the most widely misunderstood aspects of the condition, and the number attached to your diagnosis does not tell the full story of what you are experiencing or what treatment will look like.
Women in Stage 1 can experience debilitating pain. Women in Stage 4 can have surprisingly manageable symptoms. The disconnect between disease extent and lived experience is one of the most consistent findings in endometriosis research, and it continues to frustrate patients and clinicians alike. Understanding what each stage means — and, just as importantly, what it does not mean — equips patients to have more productive conversations with their care teams and to advocate for treatment that reflects their actual experience, not just their classification.
Dr. Adam Shoman at Hackensack CMIGS has diagnosed and treated endometriosis across all stages of the ASRM classification system. His approach treats the whole patient — not the number — combining surgical precision with the kind of detailed pre-operative and post-operative planning that produces consistently strong outcomes. Whether your endometriosis has been confirmed or you are in the early stages of investigation, specialist evaluation makes a significant difference.
Table of Contents
ToggleWhat Is the ASRM Endometriosis Classification System?
The American Society for Reproductive Medicine staging system for endometriosis classifies the disease into four stages based on findings at laparoscopy. Points are assigned based on the location, extent, depth of infiltration, and presence of adhesions across identified lesion sites. The total score determines the stage: Stage 1 is minimal with 1 to 5 points, Stage 2 is mild with 6 to 15 points, Stage 3 is moderate with 16 to 40 points, and Stage 4 is severe with a score above 40 points.
This scoring system is the most widely used in clinical practice and research but has known limitations. Most critically, it was designed as a tool for predicting fertility outcomes rather than pain or quality of life. Multiple studies have confirmed that ASRM stage correlates poorly with pain severity. A woman with extensive Stage 4 disease including dense ovarian adhesions may report less daily pain than a woman with Stage 1 disease who has superficial lesions near sensitive nerve tissue.
Endometriosis Stage 1: Minimal Disease
Stage 1 endometriosis is characterised by a small number of isolated superficial implants, most commonly found on the peritoneum — the lining of the pelvic cavity. There are few or no adhesions. On laparoscopy, these appear as small, flat, or slightly raised spots that may be red, clear, white, or blue-black in colour depending on their age and activity.
Despite the clinical designation of minimal, Stage 1 endometriosis is not minimal in its impact on patients. Peritoneal lesions can sit adjacent to nerve-rich tissue, particularly in the posterior cul-de-sac and uterosacral ligaments, where even small amounts of endometriosis can produce severe dysmenorrhoea and dyspareunia. Stage 1 patients who have significant pain should be treated no differently than higher-stage patients in terms of their right to symptom management and specialist care.
Endometriosis Stage 2: Mild Disease
Stage 2 endometriosis involves more implants than Stage 1, some of which may be deeper, with the total ASRM score falling between 6 and 15 points. Lesions are typically still confined to the peritoneum and ovaries, with minimal adhesive involvement. At this stage, endometriomas may begin to be present, though they are more characteristic of higher stages.
Women at Stage 2 often continue to go undiagnosed for considerable periods because their disease, while more extensive than Stage 1, may still not produce definitive findings on imaging. Transvaginal ultrasound may appear normal. The diagnosis typically requires laparoscopic evaluation. Symptoms can include worsening cyclical pain, painful intercourse, and in some cases the beginning of fertility concerns.
Endometriosis Stage 3: Moderate Disease
Stage 3, or moderate endometriosis, is characterised by multiple superficial and deep implants, small endometriomas on one or both ovaries, and filmy pelvic adhesions involving the fallopian tubes or ovaries. The ASRM score sits between 16 and 40 points. This stage represents a meaningful escalation in disease extent and is more commonly associated with fertility challenges, though the correlation between stage and fertility impairment is imperfect.
Deep infiltrating endometriosis — lesions that penetrate more than 5mm into affected tissue — may begin to appear at this stage, particularly involving the uterosacral ligaments, rectovaginal septum, or bladder. Deep infiltrating endometriosis is associated with more severe pain symptoms, particularly cyclical bowel or bladder symptoms during menstruation, and requires careful surgical planning by an experienced specialist. Treatment at Stage 3 is typically surgical, often combined with hormonal management.
Endometriosis Stage 4: Severe Disease
Stage 4 is the most extensive form of endometriosis by the ASRM classification, with a score above 40 points. It typically involves large ovarian endometriomas, extensive deep infiltrating lesions, and dense adhesions that may affect bowel, bladder, ureters, and other pelvic structures. This is the stage most associated with significant anatomical distortion of the pelvis, which can complicate both surgical access and fertility outcomes.
Despite this level of disease extent, Stage 4 does not uniformly produce the worst symptoms. Some women with Stage 4 endometriosis present primarily with infertility and report only moderate pain. The heterogeneity of presentation underscores the importance of treating symptoms and fertility goals as the primary drivers of treatment decisions, rather than stage alone. Surgical excision by a skilled minimally invasive surgeon can achieve meaningful disease clearance even in advanced cases.
The ASRM staging system is a surgical classification tool — it was not designed to predict pain, symptom severity, or fertility outcomes. Your stage is one data point among many, not a verdict on your experience or your prognosis.
Mild vs Severe Endometriosis: What Drives the Difference?
The disconnect between ASRM stage and symptom severity is largely explained by lesion location rather than disease volume. Superficial peritoneal lesions near the cul-de-sac, uterosacral ligaments, or rectovaginal septum — even when small — tend to produce more severe pain because these areas are densely innervated. By contrast, large endometriomas on the ovaries, which are classified as Stage 3 or 4, may grow silently for years if they are positioned away from nerve-rich structures.
This is why a detailed laparoscopic evaluation by an experienced surgeon is essential for accurate characterisation of endometriosis. Imaging alone — even high-quality transvaginal ultrasound or MRI — cannot identify all lesion types, particularly superficial peritoneal disease. Surgical assessment provides information that cannot be obtained any other way.
Endometriosis Stages and Fertility
All four stages of endometriosis can affect fertility, but the mechanisms differ. Minimal and mild disease may affect fertility through subtle changes in the pelvic environment — altered immune function, inflammatory cytokines, and changes in egg quality or embryo implantation. Moderate and severe disease may affect fertility more directly through mechanical distortion of the tubes and ovaries, ovarian damage from endometriomas, or extensive adhesions.
For women with endometriosis who are trying to conceive, consultation with a specialist who can assess both the surgical and reproductive dimensions of their situation is essential. In some cases, surgical excision of endometriosis lesions improves natural conception rates. In others, the most appropriate path involves a combination of surgery and assisted reproduction. The American Society for Reproductive Medicine provides evidence-based guidance on endometriosis and fertility that informs treatment planning at Hackensack CMIGS.
Treatment Options by Stage
Treatment decisions should always be guided by symptoms and patient goals rather than stage alone. As a general framework, Stages 1 and 2 are typically managed first with hormonal options including combined oral contraceptives, progesterone-only treatments, and GnRH analogues for pain control. Surgical excision or ablation at laparoscopy is offered when medical management is insufficient, when the patient prefers a more definitive approach, or when fertility is a concern.
Stages 3 and 4 more commonly call for surgical excision by an experienced laparoscopic surgeon as a primary treatment strategy, particularly for patients with endometriomas, deep infiltrating endometriosis, or significant adhesive disease. Post-operative hormonal management reduces the risk of recurrence. When bowel or bladder involvement is present, multidisciplinary care may be required.
For women with fertility goals, the decision to pursue surgery versus assisted reproduction should be made collaboratively with a specialist who understands both dimensions of their care.
Conclusion
Endometriosis staging provides useful clinical information but it does not define the totality of your experience, your prognosis, or your treatment options. Whether your endometriosis is classified as Stage 1 or Stage 4, the goal of specialist care is the same: to relieve your symptoms, protect your fertility if that is important to you, and help you achieve the best possible quality of life. The ASRM classification is a tool for surgeons — not a verdict on how much your condition deserves to be taken seriously.
If you have been diagnosed with any stage of endometriosis, or if you are experiencing symptoms that suggest it, a consultation with Dr. Shoman at Hackensack CMIGS will give you an accurate picture of your disease and the full range of options available to you. Both the Hoboken and Hasbrouck Heights offices are accepting new patients.
Frequently Asked Questions
What is the most painful stage of endometriosis?
Stage does not reliably predict pain. Stage 1 patients with lesions near nerve-rich areas can experience more severe pain than Stage 4 patients with lesions in less sensitive locations. Pain severity is driven primarily by lesion location, not disease volume.
Can Stage 1 endometriosis cause infertility?
Yes. Even minimal-stage endometriosis can affect fertility through inflammatory changes in the pelvic environment that affect egg quality, implantation, and sperm function. All stages can impact fertility, though the mechanisms vary between them.
How is Stage 3 and Stage 4 endometriosis treated?
Stage 3 and 4 endometriosis is typically managed surgically through laparoscopic excision of lesions, followed by hormonal suppression to reduce recurrence risk. The specific approach depends on lesion location, symptom burden, and fertility goals.
Does Stage 4 endometriosis mean I cannot get pregnant?
No. Stage 4 endometriosis is associated with reduced fertility, but pregnancy remains possible through natural conception or assisted reproductive technologies. Surgical treatment prior to fertility treatment may improve outcomes in selected cases.
What tests are used to stage endometriosis?
Endometriosis can only be definitively staged through laparoscopic surgery with biopsy. Imaging such as ultrasound and MRI can identify some features but cannot confirm all lesion types or assign a formal stage.
How is the ASRM classification used in treatment planning?
The ASRM classification provides a standardised framework for describing disease extent and comparing outcomes in research. Clinically, it informs surgical planning and helps predict fertility outcomes, but it should not be the sole driver of treatment decisions.
Can endometriosis progress from Stage 1 to Stage 4?
Endometriosis can progress over time in some patients, though progression is neither inevitable nor uniform. Hormonal treatment can slow or suppress progression. Regular monitoring and treatment adjustment are important components of long-term management.
Is laparoscopy the only way to diagnose endometriosis?
Currently, laparoscopy with biopsy remains the gold standard for definitive endometriosis diagnosis and staging. Non-invasive approaches are under active research but have not yet replaced surgical evaluation in clinical practice.
What is deep infiltrating endometriosis?
Deep infiltrating endometriosis refers to lesions that penetrate more than 5mm into affected tissue. It is more common in Stage 3 and 4 disease and is associated with more severe pain symptoms, particularly involving the bowel, bladder, or uterosacral ligaments.
When should I see a specialist about endometriosis?
If you experience severe period pain, pain during intercourse, cyclical bowel or bladder symptoms, or difficulty conceiving, a specialist evaluation is warranted. Early diagnosis and treatment improve long-term outcomes and quality of life.
Medical Disclaimer
This content is provided for educational purposes only and does not constitute medical advice. Endometriosis staging, diagnosis, and treatment should be managed by a qualified gynecologist with specialist experience in the condition. Individual disease presentations vary significantly and treatment decisions should be personalised to each patient’s symptoms, fertility goals, and medical history.
Dr. Adam Shoman, MD, FACOG, MBA, is the founder and lead gynecologist at Hackensack CMIGS. With extensive experience in minimally invasive gynecologic surgery, he specializes in treating complex conditions like endometriosis and fibroids using advanced technologies, such as the da Vinci Surgical System. Dr. Shoman is dedicated to patient-centered care and empowering women to take control of their health. He holds his medical degree from Alexandria University and completed his residency at Mount Sinai in New York. Dr. Shoman is a Fellow of the American College of Obstetrics and Gynecology (FACOG) and is certified in Healthcare Quality (CPHQ).
Book An Appointment
Learn More